Audit & assurance
During a recent audit of a growing SME, we uncovered several critical control weaknesses that exposed the business to unnecessary risk. These gaps were linked to rapid expansion and a lack of formalised processes. Our team worked closely with management to design practical, easy‑to‑implement solutions tailored to their operations. Key improvements included stronger approval procedures, clearer accountability structures, and enhanced monitoring checks. By embedding these measures, the company reduced exposure to potential losses and improved overall governance. The new framework also provided management with greater visibility and confidence in financial reporting. As a result, the business is now better equipped to sustain growth while maintaining robust internal controls.
Tax Credit for Research and Development
We identified a valuable tax-saving opportunity for a client in the niche manufacturing sector through their research and development (R&D) activities. After securing preliminary approval from HMRC for the company’s qualifying R&D expenditure, we successfully filed an R&D tax credit claim, resulting in a substantial tax saving. In addition, we obtained credits for the previous two accounting years via separate submissions. These claims enhanced the client’s financial position by generating both backdated and future tax credit revenue streams.
Business and Strategy Review
One of our clients experienced a sharp increase in business volume without a corresponding rise in gross or net profit, as costs were escalating in line with revenue. We were engaged to help improve profitability. Early in our review, it became clear that the existing systems could not handle the higher workload, leading to the deployment of additional resources. Working closely with management, we introduced operational efficiencies, redesigned workflows, and established Key Performance Indicators (KPIs) to better monitor and drive business performance.
Financial and Operational Due diligence
An overseas institutional investor retained us to conduct financial and operational due diligence on a pharmaceutical company owned by a private equity firm. The investor required independent validation of the company’s reported numbers and assurance that no hidden liabilities were overlooked. Our team carried out a detailed review of financial statements, accounting practices, and operational processes. We tested revenue accuracy, assessed debt obligations, and examined working capital management. We also evaluated contractual commitments and the sustainability of the business model. This thorough analysis uncovered potential exposures and risks to earnings that had not been fully addressed. We provided clear, practical recommendations to mitigate these risks and strengthen oversight. The investor gained confidence in its decision-making, supported by transparent insights into both opportunities and challenges.
